...
首页> 外文期刊>Patient Preference and Adherence >Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics
【24h】

Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics

机译:衡量和预测药物遵守的自我报告:专家们在稳定精神病门诊患者和药代动力学预测粘附的经验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The Problem: Poor adherence to appropriately prescribed medication is a global challenge for psychiatrists. Prior Studies: Measuring adherence is complicated. In our recent three-country naturalistic study including more than 1000 patients and their adherence to multiple medication prescriptions at the same time, patients’ self-report of adherence to each specific drug was the only practical option for measuring adherence. Systematic literature reviews provide inconsistent results for sociodemographic, clinical and medication variables as predictors of adherence to psychiatric drugs. Our studies over the last 10 years in relatively stable psychiatric outpatients have shown that some self-reported health beliefs had consistent, strong effects and a better predictive role. Three dimensions of these health beliefs are characteristics of the individual: 1) attitudes toward psychiatric medication such as pharmacophobia (fear of taking drugs or medicines), 2) health locus of control (the belief patients have about who or what agent determines the state of their health), 3) psychological reactance (an emotional reaction in direct contradiction to rules or regulations that threaten or suppress certain freedoms in behavior). They can be measured by the Patient Health Beliefs Questionnaire on Psychiatric Treatment. The attitude toward each specific medication can be measured by the necessity-concern framework and summarized as the presence or absence of skepticism about that drug. After 25 years conducting pharmacokinetic studies in psychiatric drugs, particularly antipsychotics, we have limited understanding of how to use blood levels to predict the effects of non-adherence or to establish it. Expert Opinion on Future Studies: Future studies to predict adherence should include the inpatient setting and explore insight. Studying the pharmacokinetics associated with non-adherence in each psychiatric drug is a major challenge. Medication adherence is a complex and dynamic process changing over time in the same patient. Personalizing adherence using psychological or pharmacological variables are in their initial stages.
机译:问题:对适当规定的药物的粘附不良是精神科医生的全球挑战。之前的研究:测量粘附复杂。在我们最近的三国自然主义研究中,包括超过1000名患者及其对多种药物处方的依恋,患者的自我报告对每个特定药物的依从性是衡量依从性的实用选择。系统文献审查为社会渗目,临床和药物变量提供了不一致的结果,作为对精神毒性粘附的预测因子。我们在过去10年中的研究表明,一些自我报告的健康信念具有一致,强烈的效果和更好的预测作用。这些健康信仰的三个维度是个人的特征:1)对精神病药物(如Pharmacophobia(恐惧服用药物或药物),2)卫生控制权(信仰患者有关于世卫组织或哪些代理人决定了谁他们的健康),3)心理抵抗力(对威胁或抑制行为中某些自由的规则或法规直接矛盾的情绪反应)。它们可以通过患者健康信仰问卷对精神科治疗来衡量。对每种特定药物的态度可以通过必要的关注框架来衡量,并总结为对该药物的存在或不存在怀疑。 25年后,在精神病药物中进行药代动力学研究,特别是抗精神病药,了解如何使用血液水平来预测非依赖或建立它的影响。关于未来研究的专家意见:预测遵守的未来研究应包括住院环境和探索洞察力。研究与每种精神病药物的非粘附相关的药代动力学是一项重大挑战。药物粘附是在同一患者中随时间变化的复杂和动态过程。使用心理或药理学变量的个性化依从性在其初始阶段。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号